Clinigence Holdings Inc ( (NUTX) ) has released its Q3 earnings. Here is a breakdown of the information Clinigence Holdings Inc presented to its investors.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Nutex Health Inc., headquartered in Houston, Texas, is a healthcare management and operations company that operates in the Hospital Division and Population Health Management Division, offering innovative healthcare models like micro-hospitals and specialty hospitals across ten states. In its recent third quarter earnings report, Nutex Health reported significant growth, including a total revenue of $222.3 million for the first nine months of 2024, marking a 25% increase from the same period in 2023. This growth was driven by a 20% increase in hospital division visits and a remarkable 159% rise in operating income. Furthermore, Nutex Health saw an adjusted EBITDA growth of 938% for the third quarter, reflecting robust operational performance. Despite these gains, the company reported a net loss attributable to Nutex Health of $8.8 million for the third quarter, influenced by non-cash stock-based compensation expenses and losses on warrant liabilities. Looking ahead, Nutex Health’s management expresses confidence in continuing its growth trajectory, focusing on enhancing cash flow and expanding its hospital and population health divisions to deliver shareholder value.
